Exploring New Pathways for the Development of "AI + Culture"

BEIJING, March 27, 2026 /PRNewswire/ — On March 27, the Creativity 2030 • 5th International Forum was held in Shougang Park, Beijing. This forum, jointly organized by the International Centre for Creativity and Sustainable Development under the auspices of UNESCO and the UNESCO Regional Office for East Asia, focused on the theme of "AI + Culture: Empowering Sustainable Development." It brought together over 150 participants, including leaders of international organizations, experts, scholars, and representatives from the business sector across more than 10 countries and regions worldwide, as well as government officials, enterprises, institutions, and academic representatives from over 20 cities across China. Participants engaged in multifaceted dialogues and exchanges on topics including the preservation of cultural expression diversity in the AI era, as well as the transformation and sustainable development of creative industries.


This is the first "AI + Culture" themed forum held by UNESCO in China. During the forum, the UNESCO Regional Office for East Asia officially announced the launch of the "2026-2027 TechCul Dialogues: AI + Culture in East and Southeast Asia." The "2025 Cases on Protecting and Promoting the Diversity of Cultural Expressions in the Digital Environment," organized by the International Centre for Creativity and Sustainable Development under the auspices of UNESCO, were simultaneously released.

 

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

Yiwu Global Digital Trade Center Nears Grand Opening, Sparking Buzz with Global Buyers Through Short Dramas and AI-Driven Videos

YIWU, China, Oct. 9, 2025 /PRNewswire/ — This autumn, Yiwu is poised…

Fujitsu develops multi-AI agent collaboration technology to optimize supply chains, launches joint trials

Securely connecting AI agents across multiple companies for rapid response to changing…

Asieris Releases Phase III Clinical Study and Real-World Research Data for APL-1706, a Bladder Cancer Diagnosis and Management Drug, at the 2024 ASCO-GU

SHANGHAI, Jan. 29, 2024 /PRNewswire/ — Asieris Pharmaceuticals (Stock Code: 688176.SH), a global…